1489 studies found for:    Open Studies | "Breast Diseases"
Show Display Options
Rank Status Study
21 Recruiting Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors
Condition: Breast Cancer
Interventions: Device: Focused Microwave Thermotherapy;   Drug: Chemotherapy (control)
22 Unknown  Women At Risk: The High Risk Breast Cancer Program
Condition: Breast Cancer
Intervention:
23 Recruiting Medical Radiometer - RTM - 01 - RES and Its Use in Detecting Hotspots in Female Breast
Condition: Breast Cancer
Intervention: Device: Microwave Thermography RTM-01-RES
24 Not yet recruiting Fulvestrant and Palbociclib in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery
Conditions: Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Fulvestrant;   Other: Laboratory Biomarker Analysis;   Drug: Palbociclib;   Other: Questionnaire Administration
25 Recruiting Fatigue in Breast Cancer Patients Undergoing Radiotherapy-eSMART-MH
Condition: Breast Cancer
Interventions: Behavioral: eSMART-MH;   Other: Mobile Mood Tracking (Mood 24/7);   Behavioral: Theater Testing Workshop
26 Not yet recruiting KORTUC: Phase I 'Run in' Study Followed by Randomised Phase II Trial Testing Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Women With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response
Condition: Breast Cancer
Intervention: Drug: Hydrogen Peroxide
27 Not yet recruiting MLN0128 in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy
Condition: Breast Neoplasms
Interventions: Drug: Fulvestrant;   Drug: MLN0128
28 Recruiting Trial to Compare Radiation Fibrosis With Five Versus Three Fractions
Condition: Malignant Neoplasm of Breast Stage I
Interventions: Radiation: Arm 1 600 cGY x 5 fractions;   Radiation: Arm 2 800 cGY x 3 fractions
29 Not yet recruiting A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Condition: Carcinoma Breast Stage IV
Interventions: Drug: Pembrolizumab;   Drug: Carboplatin;   Drug: Gemcitabine
30 Not yet recruiting Acupuncture for Post-Mastectomy Pain Syndrome (PMPS)
Condition: Malignant Neoplasm of Breast
Interventions: Procedure: Electro-Acupuncture;   Procedure: Sham Electro-Acupuncture;   Other: Standard of Care;   Behavioral: Questionnaires
31 Not yet recruiting Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 Negative
Condition: Breast Cancer
Intervention: Drug: Combination of ribociclib + capecitabine
32 Recruiting Treatment of Canadian Postmenopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy
Condition: HR+ HER2- Postmenopausal Advanced Breast Cancer
Interventions: Drug: Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant;   Drug: Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
33 Not yet recruiting Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)
Condition: Metastatic Breast Cancer
Interventions: Drug: Eribulin mesylate;   Other: Biologic: PEGylated recombinant human hyaluronidase (PEGPH20);   Other: Biologic: PEGylated recombinant human hyaluronidase
34 Not yet recruiting Estrogen Receptor-Positive Breast Cancer Patient-Derived Xenografts
Condition: Breast Cancer
Intervention:
35 Not yet recruiting Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Pembrolizumab;   Drug: Nab-Paclitaxel
36 Not yet recruiting Reliability and Validity of Self-measured Arm Circumference in Women With Breast Cancer
Conditions: Lymphedema;   Breast Cancer
Intervention: Procedure: Self-measured arm circumference, therapist-measured arm-circumference, perometer-measured arm circumference
37 Not yet recruiting Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy
Condition: Breast Cancer
Intervention: Procedure: Axillary Lymph Node Sampling Clip
38 Not yet recruiting Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer
Conditions: Stage III Breast Cancer (T0N2, T1N2, T2N2, T3N1, 2 or T4);   Stage IIb Breast Cancer (T3N0)
Intervention: Other: Whole-body FDG PET-CT alone
39 Recruiting Nano MRI on 7 Tesla in Rectal and Breast Cancer
Conditions: Rectal Neoplasms;   Breast Neoplasms
Interventions: Drug: ferumoxtran-10;   Device: 7 Tesla MRI;   Device: 3 Tesla MRI
40 Not yet recruiting Study of ETBX-021 in Subjects With HER2-Expressing Breast Cancer
Condition: Cancer
Intervention: Biological: ETBX-021

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years